📢 Gate Square #Creator Campaign Phase 2# is officially live!
Join the ZKWASM event series, share your insights, and win a share of 4,000 $ZKWASM!
As a pioneer in zk-based public chains, ZKWASM is now being prominently promoted on the Gate platform!
Three major campaigns are launching simultaneously: Launchpool subscription, CandyDrop airdrop, and Alpha exclusive trading — don’t miss out!
🎨 Campaign 1: Post on Gate Square and win content rewards
📅 Time: July 25, 22:00 – July 29, 22:00 (UTC+8)
📌 How to participate:
Post original content (at least 100 words) on Gate Square related to
Windtree signs a new financing protocol of 520 million USD to strengthen its BNB reserve strategy.
ChainCatcher news, Nasdaq-listed biotechnology company Windtree Therapeutics (WINT) announced that it has signed a common stock purchase agreement of up to $500 million to establish an equity line of credit (ELOC). In addition, the company has also signed an additional stock purchase agreement worth $20 million with Build and Build Corp. The total financing scale reaches up to 520 million dollars, of which 99% of the funds will be used to purchase BNB. The company plans to officially start using the funds after obtaining shareholder approval to increase the authorized number of common stocks.